Literature DB >> 22532509

Accuracy of pharmacy and coded-diagnosis information in identifying tuberculosis in patients with rheumatoid arthritis.

Christina T Fiske1, Marie R Griffin, Ed Mitchel, Timothy R Sterling, Carlos G Grijalva.   

Abstract

PURPOSE: Previous studies suggest that disease-modifying anti-rheumatic drugs (DMARDs) increase tuberculosis (TB) risk. The accuracy of pharmacy and coded-diagnosis information to identify persons with TB is unclear.
METHODS: Within a cohort of rheumatoid arthritis (RA) patients (2000-2005) enrolled in Tennessee Medicaid, we identified those with potential TB using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD9-CM) diagnosis codes and/or pharmacy claims. Using the Tennessee TB registry as the gold standard for identification of TB, we estimated the sensitivity, specificity, predictive values, and the respective 95% confidence intervals for each TB case-ascertainment strategy.
RESULTS: Ten of 18,094 RA patients had confirmed TB during 61,461 person-years of follow-up (16.3 per 100,000 person-years). The sensitivity and positive predictive value (PPV) and respective 95% confidence intervals were low for confirmed TB based on ICD9-CM codes alone (60.0% (26.2-87.8) and 1.3% (0.5-2.9)), pharmacy data alone (20% (2.5-55.6) and 4.1% (0.5-14.3)), and both (20% (2.5-55.6) and 25.0% (3.2-65.1)).
CONCLUSIONS: Algorithms that use administrative data alone to identify TB have a poor PPV that results in a high false positive rate of TB detection.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22532509      PMCID: PMC3371104          DOI: 10.1002/pds.3243

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  10 in total

1.  American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.

Authors:  Kenneth G Saag; Gim Gee Teng; Nivedita M Patkar; Jeremy Anuntiyo; Catherine Finney; Jeffrey R Curtis; Harold E Paulus; Amy Mudano; Maria Pisu; Mary Elkins-Melton; Ryan Outman; Jeroan J Allison; Maria Suarez Almazor; S Louis Bridges; W Winn Chatham; Marc Hochberg; Catherine MacLean; Ted Mikuls; Larry W Moreland; James O'Dell; Anthony M Turkiewicz; Daniel E Furst
Journal:  Arthritis Rheum       Date:  2008-06-15

2.  The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy.

Authors:  Kevin L Winthrop; Roger Baxter; Liyan Liu; Bentson McFarland; Donald Austin; Cara Varley; LeAnn Radcliffe; Eric Suhler; Dongsoek Choi; Lisa J Herrinton
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-12-10       Impact factor: 2.890

3.  Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-05-02

4.  Antirheumatic drugs and the risk of tuberculosis.

Authors:  Paul Brassard; Abbas Kezouh; Samy Suissa
Journal:  Clin Infect Dis       Date:  2006-08-10       Impact factor: 9.079

5.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

6.  Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis.

Authors:  S Bernatsky; M Hudson; S Suissa
Journal:  Rheumatology (Oxford)       Date:  2007-05-03       Impact factor: 7.580

7.  Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada.

Authors:  Paul Brassard; Anne-Marie Lowe; Sasha Bernatsky; Abbas Kezouh; Samy Suissa
Journal:  Arthritis Rheum       Date:  2009-03-15

8.  Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.

Authors:  Juan J Gómez-Reino; Loreto Carmona; Vicente Rodríguez Valverde; Emilio Martín Mola; Maria Dolores Montero
Journal:  Arthritis Rheum       Date:  2003-08

9.  Validation of rheumatoid arthritis diagnoses in health care utilization data.

Authors:  Seo Young Kim; Amber Servi; Jennifer M Polinski; Helen Mogun; Michael E Weinblatt; Jeffrey N Katz; Daniel H Solomon
Journal:  Arthritis Res Ther       Date:  2011-02-23       Impact factor: 5.156

10.  Pharmacy data for tuberculosis surveillance and assessment of patient management.

Authors:  Deborah S Yokoe; Steven W Coon; Rachel Dokholyan; Michael C Iannuzzi; Timothy F Jones; Sarah Meredith; Marisa Moore; Lynelle Phillips; Wayne Ray; Stephanie Schech; Deborah Shatin; Richard Platt
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

  10 in total
  5 in total

1.  Use of state administrative data sources to study adolescents and young adults with rare conditions.

Authors:  J A Royer; J W Hardin; S McDermott; L Ouyang; J R Mann; O D Ozturk; J Bolen
Journal:  J Gen Intern Med       Date:  2014-08       Impact factor: 5.128

2.  Not So Fast: Slowing Tuberculosis Decline in California.

Authors:  Julie Higashi; Pennan Barry
Journal:  Am J Public Health       Date:  2019-02       Impact factor: 9.308

3.  A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis.

Authors:  Sara G Murray; Gabriela Schmajuk; Laura Trupin; Erica Lawson; Matthew Cascino; Jennifer Barton; Mary Margaretten; Patricia P Katz; Edward H Yelin; Jinoos Yazdany
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

4.  Understanding the burden of tuberculosis among American Indians/Alaska Natives in the U.S.: a validation study.

Authors:  Laura Jean Podewils; Emily Alexy; Stephani Jean Driver; James E Cheek; Robert C Holman; Dana Haberling; Meghan Brett; Eugene McCray; John T Redd
Journal:  Public Health Rep       Date:  2014 Jul-Aug       Impact factor: 2.792

5.  Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.

Authors:  Saurabh Gupta; Kenneth Ronald Gersing; Alaattin Erkanli; Tal Burt
Journal:  Psychiatr Q       Date:  2016-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.